Narcan Nasal Spray, an opioid antagonist, is indicated for the reversal of known or suspected opioid overdose, including respiratory and/or central nervous system (CNS) depression. It was initially approved by the Food and Drug Administration (FDA) in November 2015 as a 4mg strength nasal spray and later approved in a 2mg strength in January 2017. It is supplied as a single-dose spray in 2-count packs.
In accordance with the Centers for Disease Control and Prevention (CDC) recommendations, pharmacists at Walgreens will also be tasked with educating patients about Narcan when they are dispensed a controlled substance >50 morphine milligram equivalents (MME).
“By stocking Narcan in all our pharmacies, we are making it easier for families and caregivers to help their loved ones by having it on hand in case it is needed,” said Rick Gates, Walgreens group vice president of pharmacy.
Walgreens operates over 8,000 pharmacies nationwide and offers naloxone without a prescription in 45 states.
For more information visit walgreens.com.